Granite Point Capital Management, L.P. - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.7%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q1 2017$350,000
-6.9%
3,5000.0%0.10%
-65.0%
Q4 2016$376,000
-77.6%
3,500
-74.1%
0.30%
-54.3%
Q3 2016$1,680,000
-22.9%
13,500
-11.8%
0.66%
+101.2%
Q4 2015$2,180,000
+21.4%
15,300
-23.5%
0.33%
-73.5%
Q3 2015$1,796,000
-46.5%
20,000
-31.4%
1.23%
+26.0%
Q2 2015$3,358,000
-12.1%
29,160
-27.1%
0.98%
-30.2%
Q1 2015$3,820,000
+42.1%
40,0000.0%1.40%
+11.0%
Q4 2014$2,689,000
+42.4%
40,000
+14.3%
1.26%
+34.0%
Q3 2014$1,889,000
+21.4%
35,0000.0%0.94%
-12.2%
Q2 2014$1,556,00035,0001.07%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q4 2015
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 8,344,200$960,918,0007.67%
RUDMAN ERROL M 130,201$14,994,0005.06%
Ativo Capital Management LLC 59,101$7,258,0002.56%
Kylin Management 188,226$21,676,0002.36%
Monashee Investment Management LLC 40,000$4,606,0002.17%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 62,866$7,240,0001.91%
Cormorant Asset Management, LP 111,500$12,840,0001.71%
OBERWEIS ASSET MANAGEMENT INC/ 53,500$6,161,0001.63%
Perceptive Advisors 147,604$16,998,0001.02%
Granite Point Capital Management, L.P. 29,160$3,358,0000.98%
View complete list of CHINA BIOLOGIC PRODS INC shareholders